CAR-T

Category: Popular Science

Keywords: CAR-T , immunotherapy , personalized medicine , cancer therapy , large B cell lymphoma , leukemia

Description: This hub is created to discuss CAR-T cell therapy for cancer treatment such as leukemia, large B cell lymphoma.

Pinned Content Last updated 2 years ago

CAR-T therapies are progressing to the market at a much faster rate. Novartis just received approval from Australian authorities to make it's CAR-T therapy available to all eligible patients. Additionally, Bristol-Myers Squibb also received FDA approval in the US for it's CAR-T cell therapy for adults with relapsed large B-cell lymphoma. Kite Pharma already has FDA approved CAR-T cell therapy for the same in the market for a while now. Seems like all major Pharma/Biotech companies will soon embrace CAR-T's, leading to more competition and hopefully making these therapies more affordable as a result. Below is a link to the latest advancements in CAR-T's by biopharma reporter.

Links: https://www.biopharma-reporter.com/Article/2021/02/15/Scientific-breakthroughs-approvals-Latest-CAR-T-cell-therapy-related-developments#:~:text=Earlier%20this%20month%2C%20the%20US,directed%20CAR%20T%2Dcell%20immunotherapy.

Live Board
Archived 1

Archived Board	Archived Date	Discussions
CAR-T's discussion		12

Archived Board	Archived Date	Discussions
CAR-T's discussion		12

4 members: Owner

Harwinder

Patrick

Neil

Wai

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started